Cargando…
Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?
BACKGROUND: Empiric triple treatments for Helicobacter pylori (H. pylori) are increasingly unsuccessful. We evaluated factors associated with failure of these treatments in the central region of Portugal. METHODS: This single-center, prospective study included 154 patients with positive (13)C-urea b...
Autores principales: | Almeida, Nuno, Donato, Maria Manuel, Romãozinho, José Manuel, Luxo, Cristina, Cardoso, Olga, Cipriano, Maria Augusta, Marinho, Carol, Fernandes, Alexandra, Calhau, Carlos, Sofia, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339300/ https://www.ncbi.nlm.nih.gov/pubmed/25886722 http://dx.doi.org/10.1186/s12876-015-0245-y |
Ejemplares similares
-
An Unusual Endoscopic Image of a Submucosal Angiodysplasia
por: Carvalho, Rita, et al.
Publicado: (2012) -
Helicobacter Pylori Eradication Therapy: Still a Challenge
por: Hafeez, Muhammad, et al.
Publicado: (2021) -
Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy
por: Liou, Jyh-Ming, et al.
Publicado: (2022) -
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
por: Branquinho, Diogo, et al.
Publicado: (2017) -
Functional Plasticity in the Type IV Secretion System of Helicobacter pylori
por: Barrozo, Roberto M., et al.
Publicado: (2013)